Design and implementation of fluidic micro-pulleys for flow control on centrifugal microfluidic platforms

Microfluidic discs have been employed in a variety of applications for chemical analyses and biological diagnostics. These platforms offer a sophisticated fluidic toolbox, necessary to perform processes that involve sample preparation, purification, analysis, and detection. However, one of the weaknesses of such systems is the uni-directional movement of fluid from the disc centre to its periphery due to the uni-directionality of the propelling centrifugal force. Here we demonstrate a mechanism for fluid movement from the periphery of a hydrophobic disc towards its centre that does not rely on the energy supplied by any peripheral equipment. This method utilizes a ventless fluidic network that connects a column of working fluid to a sample fluid. As the working fluid is pushed by the centrifugal force to move towards the periphery of the disc, the sample fluid is pulled up towards the centre of the disc analogous to a physical pulley where two weights are connected by a rope passed through a block. The ventless network is analogous to the rope in the pulley. As the working fluid descends, it creates a negative pressure that pulls the sample fluid up. The sample and working fluids do not come into direct contact, and it allows the freedom to select a working fluid with physical properties markedly different from those of the sample. This article provides a demonstration of the "micro-pulley" on a disc, discusses underlying physical phenomena, provides design guidelines for fabrication of micro-pulleys on discs, and outlines a vision for future micro-pulley applications.close0

Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial.

The dissemination in the central nervous system (CNS) is an uncommon but fatal complication occurring in patients with diffuse large B-cell lymphoma (DLBCL). Standard prophylaxis has been demonstrated to reduce CNS relapse and improve survival rates. Intrathecal (IT) liposomal cytarabine allows maintaining elevated drug levels in the cerebrospinal fluid for an extended period of time. Data on the efficacy and safety of liposomal cytarabine as CNS prophylaxis in patients with DLBCL are still insufficient. The objective of the present study was to evaluate the effectiveness and safety of the prophylaxis with IT liposomal cytarabine in prevention of CNS relapse in high-risk patients with DLBCL who were included in a trial of first line systemic therapy with 6 cycles of dose-dense R-CHOP every 14 days. Twenty-four (18.6 %) out of 129 patients were identified to have risk factors for CNS involvement, defined as follows: >30 % bone marrow infiltration, testes infiltration, retroperitoneal mass ≥10 cm, Waldeyer ring, or bulky cervical nodes involvement. Liposomal cytarabine (50 mg) was administered by lumbar puncture the first day of the 1st, 2nd, and 6th cycle of R-CHOP14 scheme. Among 70 IT infusions, grade 3-4 adverse events reported were headache (one patient) and nausea/vomiting (one patient). With a median follow-up of 40.1 months, no CNS involvement by DLBCL was observed in any patient. In conclusion, IT liposomal cytarabine is safe, feasible, and effective for CNS prophylaxis, causing few associated risks and little discomfort to patients with DLBCL.The study was conducted with the help of a grant from BRedes Temáticas de Investigación Cooperativa en Cáncer (RTICC)